CONSENSUS I was a randomised, double-blind, placebo-controlled trial of 253 patients with severe heart failure.
When enalapril was added to the conventional heart failure therapy there was a significant 27% reduction in mortality in patients with severe heart failure.
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.